International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

LEARN MORE

Ergotamine Tartrate 2-mg Sublingual Tablets

Author(s): Allen Loyd V Jr

Issue: May/Jun 2003 - Diabetes and Wound Care
View All Articles in Issue

Page(s): 219

Ergotamine Tartrate 2-mg Sublingual Tablets Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Ergotamine Tartrate 2-mg Sublingual Tablets. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: ergotamine, sublingual, tablet, headache, migraine, discontinued

Related Categories: FORMULATIONS, PAIN MANAGEMENT, DISCONTINUED FORMULATIONS

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Ergotamine Tartrate 2-mg Sublingual Tablets Allen Loyd V Jr	May/Jun 2003 Pg. 219
Ergotamine Tartrate 1-mg and Caffeine 100-mg Capsules Allen Loyd V Jr	Nov/Dec 2012 Pg. 506
A Concise Discussion of Headache Types, Part 3: Migraine Williams LaVonn A, Allen Loyd V Jr	Jul/Aug 2012 Pg. 270-274
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Lorazepam 2-mg Sublingual Tablets Allen Loyd V Jr	Mar/Apr 2003 Pg. 138
Migraine Headache Suppositories Allen Loyd V Jr	May/Jun 2023 Pg. 237
Ergotamine Tartrate, Caffeine, Hyoscyamine Sulfate and Pentobarbital Sodium Suppositories Allen Loyd V Jr	Mar/Apr 1998 Pg. 151
Medications Discontinued in the United States Ashworth Lisa D	May/Jun 2002 Pg. 193
An Alternative Approach to Tablet Splitting and Grinding for Medication Administration Taneja Rajneesh, Scarim Joseph, Pande Poonam G, Scarim Anthony, Nahata Milap C, Jew Rita K, Inabathina Koteswara Rao	May/Jun 2023 Pg. 240-249
Molding as Innovative Technology for Personalized Tablet Production Mady Omar Y, Al-Shoubki Adam A, Hagag Youssef, Ibrahim Bakry, Donia Ahmed A	Mar/Apr 2022 Pg. 163-174
Comparison of Disintegrant-addition Methods on the Compounding of Orodispersible Tablets Mahesparan Vishnu A/L, Bin Abd Razak Fashli Syafiq, Ming Long Chiau, Uddin ABM Helal, Sarker Md Zaidul Islam, Bin Liew Kai	Mar/Apr 2020 Pg. 148-155
Estriol 2-mg and Estradiol 0.5-mg/0.1-mL Sublingual Drops Allen Loyd V Jr	Jul/Aug 2002 Pg. 300
A Concise Discussion of Headache Types, Part 2: Migraine Williams LaVonn A	May/Jun 2012 Pg. 182-188
Medications Discontinued in the United States Ashworth Lisa D	Jul/Aug 2002 Pg. 286-287
Formulation Development and Stability Testing of Extemporaneous Suspension Prepared From Dapsone Tablets Kaila Nitin, El-Ries Mohamed, Riga A, Alexander Kenneth S, Dollimore D	May/Jun 2003 Pg. 233-239
Application of Co-processed Excipient as a Novel Method to Compound Orally Disintegrating Tablets Liew Kai Bin, Hii Shou Hui, Chew Yik Ling, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam	May/Jun 2022 Pg. 255-263
Recent Formulation Advances and Preparation of Orally Disintegrating Tablets Ejeta Fikadu	Sep/Oct 2022 Pg. 370-377
Investigation of Filler Effects on the Compounding of Freeze-dried Orodispersible Tablets Containing Annona muricata Extract Azman Syahiera Ezzah Noor, Abd Razak Fashli Syafiq, Kamal Wan Hamirul Bahrin Wan, Zheng Gan Kok, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam, Bin Liew Kai	Nov/Dec 2020 Pg. 509-514
Enhancing Hormonal Tablets Disintegration: The Role of Chitosan as an Alternative Disintegrant in Estradiol Tablet Formulation Sembiring Mikael Ham, Riadi Taufik, Arsyadi	Sep/Oct 2024 Pg. 432-439
Basics of Compounding for Cough Allen Loyd V Jr	Nov/Dec 2004 Pg. 462-465
Return to Top